NCCN Guidelines® Insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN Guidelines Journal Article


Authors: Pallera, A.; Altman, J. K.; Berman, E.; Abboud, C. N.; Bhatnagar, B.; Curtin, P.; DeAngelo, D. J.; Gotlib, J.; Tanner Hagelstrom, R.; Hobbs, G.; Jagasia, M.; Kantarjian, H. M.; Kropf, P.; Metheny, L.; Moore, J. O.; Ontiveros, E.; Purev, E.; Quiery, A.; Reddy, V. V. B.; Rose, M. G.; Shah, N. P.; Douglas Smith, B.; Snyder, D. S.; Sweet, K. L.; Tibes, R.; Yang, D. T.; Gregory, K.; Sundar, H.; Deininger, M.; Radich, J. P.
Article Title: NCCN Guidelines® Insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN Guidelines
Abstract: The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for the management of chronic-phase and advanced-phase CML in adult patients. The median age of disease onset is 67 years. However, because CML occurs in all age groups, clinical care teams should be prepared to address issues relating to fertility and pregnancy with patients who are of reproductive age at the time of diagnosis. CML is relatively rare in children and there are no evidence-based recommendations for the management of CML in pediatric population. These NCCN Guidelines Insights discuss special considerations for the management of CML during pregnancy and for the management of CML in the pediatric population. © 2016 JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 14
Issue: 12
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2016-12-01
Start Page: 1505
End Page: 1512
Language: English
PROVIDER: scopus
PUBMED: 27956535
DOI/URL:
Notes: Review -- Export Date: 3 January 2017 -- Source: Scopus
Citation Impact
MSK Authors
  1. Ellin Berman
    173 Berman
Related MSK Work